Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

Also called NCT07706075

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Muhammad Ali Javed (from the registry)
Registry
  • NCT NCT07706075
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07706075. Randomized; single masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2027-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)
Condition
Atrial Fibrillation (AF)
Condition
Atrial Fibrillation With Rapid Ventricular Response
Intervention (Drug)
Verapamil Hydrochloride
Intervention (Drug)
Metoprolol tartrate
Lead sponsor
Muhammad Ali Javed (class: other)

Record details

Record id
cardio:ct-nct07706075
Content hash
158607125a4fa7e4cb55429b7d6798c779b16ca5e24de8f76dc1bfc07a72fd57